Advanced search
Publication Cover
Fetal and Pediatric Pathology Volume 42, 2023 - Issue 3
Submit an article Journal homepage
193
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Bilateral Ovarian Sertoli-Leydig Cell Tumors Harboring DICER1 Germline and Distinct Somatic Mutations: Case Report and Literature Review

Caitlin E Hughesa Department of Pediatric Pathology, Monroe Carell Jr. Children’s Hospital at Vanderbilt, Nashville, TN, USA
,
Jiancong Lianga Department of Pediatric Pathology, Monroe Carell Jr. Children’s Hospital at Vanderbilt, Nashville, TN, USAORCID Iconhttps://orcid.org/0000-0002-7215-4346
ORCID Icon,
Vera Paulsonb Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA
&
Huiying Wanga Department of Pediatric Pathology, Monroe Carell Jr. Children’s Hospital at Vanderbilt, Nashville, TN, USACorrespondence[email protected]
Pages 472-478 | Received 30 Jun 2022, Accepted 12 Jul 2022, Published online: 19 Sep 2022

References

  • Foulkes WD, Priest JR, Duchaine TF. DICER1: mutations, microRNAs and mechanisms. Nat Rev Cancer. 2014;14(10):662–72. doi:10.1038/nrc3802.
  • Stewart CJ, Charles A, Foulkes WD. Gynecologic manifestations of the DICER1 syndrome. Surg Pathol Clin. 2016;9(2):227–41. doi:10.1016/j.path.2016.01.0.
  • Witkowski L, Mattina J, Schönberger S, Murray MJ, Choong CS, Huntsman DG, Reis-Filho JS, McCluggage WG, Nicholson JC, Coleman N. [Erratum: DICER1 hotspot mutations in non-epithelial gonadal tumours. Br J Cancer. 2013;109(12):3131. doi:10.1038/bjc.2013.637.
  • Schultz KAP, Harris AK, Finch M, Dehner LP, Brown JB, Gershenson DM, Young RH, Field A, Yu W, Turner J, et al. DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry. Gynecol Oncol. 2017;147(3):521–7. doi:10.1016/j.ygyno.2017.09.034.
  • Heravi-Moussavi A, Anglesio MS, Cheng S-WG, Senz J, Yang W, Prentice L, Fejes AP, Chow C, Tone A, Kalloger SE, et al. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers. N Engl J Med. 2012;366(3):234–42. doi:10.1056/NEJMoa1102903.
  • de Kock L, Terzic T, McCluggage WG, Stewart CJR, Shaw P, Foulkes WD, Clarke BA. DICER1 mutations are consistently present in moderately and poorly differentiated Sertoli-Leydig cell tumors. Am J Surg Pathol. 2017;41(9):1178–87. doi:10.1097/PAS.0000000000000895.
  • McCluggage WG, Chong AL, de Kock L, Foulkes WD. Somatic tumour testing establishes that bilateral DICER1-associated ovarian Sertoli-Leydig cell tumours represent independent primary neoplasms. Histopathology. 2020;77(2):223–30. doi:10.1111/his.14123.
  • Goulvent T, Ray-Coquard I, Borel S, Haddad V, Devouassoux-Shisheboran M, Vacher-Lavenu M-C, Pujade-Laurraine E, Savina A, Maillet D, Gillet G, et al. DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study. Histopathology. 2016;68(2):279–85. doi:10.1111/his.12747.
  • Slade I, Bacchelli C, Davies H, Murray A, Abbaszadeh F, Hanks S, Barfoot R, Burke A, Chisholm J, Hewitt M, et al. DICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome. J Med Genet. 2011;48(4):273–8. doi:10.1136/jmg.2010.083790.
  • Rutter MM, Jha P, Schultz KAP, Sheil A, Harris AK, Bauer AJ, Field AL, Geller J, Hill DA. DICER1 mutations and differentiated thyroid carcinoma: evidence of a direct association. J Clin Endocrinol Metab. 2016;101(1):1–5. doi:10.1210/jc.2015-2169.
  • Chen KS, Stuart SH, Stroup EK, Shukla AS, Wang J, Rajaram V, Vujanic GM, Slone T, Rakheja D, Amatruda JF, et al. Distinct DICER1 hotspot mutations identify bilateral tumors as separate events. JCO Precis Oncol. 2018;2(2):1–9. doi:10.1200/PO.17.00113.
  • Darrat I, Bedoyan JK, Chen M, Schuette JL, Lesperance MM. Novel DICER1 mutation as cause of multinodular goiter in children. Head Neck. 2013;35(12):E369–E371. doi:10.1002/hed.23250.
  • Conlon N, Schultheis AM, Piscuoglio S, Silva A, Guerra E, Tornos C, Reuter VE, Soslow RA, Young RH, Oliva E, et al. A survey of DICER1 hotspot mutations in ovarian and testicular sex cord-stromal tumors. Mod Pathol. 2015;28(12):1603–12. doi:10.1038/modpathol.2015.115.
  • Luke AM, Moroney JW, Snitchler A, Whiteway SL. Ovarian Sertoli-Leydig cell tumor with elevated inhibin b as a cause of secondary amenorrhea in an adolescent with germ line DICER1 mutation. J Pediatr Adolesc Gynecol. 2017;30(5):598–600. doi:10.1016/j.jpag.2017.05.002.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.